Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 814
Filter
2.
Int J Mol Sci ; 25(7)2024 Mar 22.
Article in English | MEDLINE | ID: mdl-38612416

ABSTRACT

Acute kidney injury (AKI) is a public health burden with increasing morbidity and mortality rates and health care costs. Acute tubular necrosis (ATN) is the most common cause of AKI. Cisplatin (CIS) is a platinum-based chemotherapeutic agent used in the treatment of a wide variety of malignancies such as lung, breast, ovary, testis, bladder, cervix, and head and neck cancers. Autophagy plays an important role in AKI. Galectin-3 (Gal-3) is significantly increased in renal tubules in AKI; however, its role in autophagy is not well understood. Male C57B6/J and B6.Cg-Lgals3 /J Gal-3 knockout (KO) mice were used to induce AKI using a CIS mouse model of ATN. Renal Gal-3 and autophagy proteins' expression were measured using standard histologic, immunofluorescent, and enzyme-linked immunosorbent assay techniques. The data were presented as the mean ± S.E. Statistically significant differences (p < 0.05) were calculated between experimental groups and corresponding control groups by one-way analysis of variance. There was a significant increase in renal concentrations of Gal-3 in the Gal-3 wild-type CIS-treated mice when compared with sham control mice. There were significantly higher concentrations of renal LC3B, ATG13, Ulk-1, Beclin, ATG5, ATG12, ATG9A, and p-AMPK in the CIS-treated Gal-3 KO mice than in the Gal-3 wild-type CIS-treated mice. Further, there were significantly higher concentrations of mTOR, p- NF-κB, beta-catenin, and p62 in the kidneys of the Gal-3 wild-type CIS-treated mice than in the Gal-3 KO CIS-treated mice. Our findings affirm the connection between Gal-3 and autophagy, revealing its central role as a connector with prosurvival signaling proteins. Gal-3 plays a pivotal role in orchestrating cellular responses by interacting with prosurvival signal pathways and engaging with autophagy proteins. Notably, our observations highlight that the absence of Gal-3 can enhance autophagy in CIS-induced ATN.


Subject(s)
Acute Kidney Injury , Kidney Cortex Necrosis , Animals , Male , Mice , Autophagy , Cisplatin/adverse effects , Cisplatin/pharmacology , Galectin 3/genetics , Kidney , Necrosis
3.
Medicine (Baltimore) ; 102(43): e35719, 2023 Oct 27.
Article in English | MEDLINE | ID: mdl-37904359

ABSTRACT

RATIONALE: Dengue fever is a widespread mosquito-borne viral disease, most prevalent in the tropical and subtropical areas of the world. There has been a significant rise in the incidence and number of outbreaks of dengue in recent years, which has made it a matter of global concern. It may be associated with a number of renal complications, ranging from hematuria, proteinuria, glomerulonephritis, and acute tubular necrosis. However, renal cortical necrosis (RCN) is a rare renal complication of this disease. PATIENTS CONCERNS: We report the case of a young gentleman who presented with fever, vomiting, and anuria. On workup, he was found to be having complicated Dengue fever with RCN resulting in acute renal failure. DIAGNOSIS: To the best of our knowledge, RCN is not a reported renal complication of dengue fever. INTERVENTIONS AND OUTCOMES: Our report highlights the importance of early consideration of renal cortical necrosis in patients with dengue fever and persistent anuria. LESSON: This would allow for better disease prognostication while enabling physicians to develop more effective treatment strategies.


Subject(s)
Anuria , Dengue , Kidney Cortex Necrosis , Male , Humans , Kidney Cortex Necrosis/etiology , Anuria/complications , Treatment Outcome , Hematuria , Dengue/complications , Dengue/diagnosis
4.
Kidney360 ; 4(1): 83-91, 2023 01 01.
Article in English | MEDLINE | ID: mdl-36700908

ABSTRACT

Pauci-immune focal necrotizing glomerulonephritis (piFNGN) involves asynchronous onset and progression of injurious lesions in biopsies. Pathologists can describe this heterogeneity within a biopsy, but translating the information into prognostic or expression analyses is challenging. Understanding the underlying molecular processes could improve treatment; however, bulk or single-cell transcriptomic analyses of dissociated tissue disregard the heterogeneity of glomerular injury. We characterize protein and mRNA expression of individual glomeruli in 20 biopsies from 18 patients with antineutrophil cytoplasmic antibody-associated piFNGN using the NanoString digital spatial profiling (DSP) platform. For this purpose, circular annotations of glomeruli were analyzed using protein, immuno-oncology RNA, and Cancer Transcriptome Atlas panels (n=120, 72, and 48 glomeruli, respectively). Histologic evaluation of glomerular patterns of injury was performed in adjacent serial sections. Expression data were processed by log2 transformation, quantile normalization, and batch adjustment. DSP revealed distinct but overlapping gene expression profiles relating to the morphological evolution of injurious lesions, including dynamic expression of various immune checkpoint regulators. Enrichment analysis indicated deregulated pathways that underline known and highlight novel potential mechanisms of disease. Moreover, by capturing individual glomeruli, DSP describes heterogeneity between and within biopsies. We demonstrate the benefit of spatial profiling for characterization of heterogeneous glomerular injury, indicating novel molecular correlates of glomerular injury in piFNGN.


Subject(s)
Glomerulonephritis, IGA , Glomerulonephritis , Kidney Cortex Necrosis , Humans , Glomerulonephritis/genetics , Glomerulonephritis/pathology , Kidney Glomerulus/chemistry , Kidney Glomerulus/pathology , Glomerulonephritis, IGA/pathology , Antibodies, Antineutrophil Cytoplasmic/analysis , Kidney Cortex Necrosis/pathology , Gene Expression
5.
J Am Soc Nephrol ; 33(3): 472-486, 2022 03.
Article in English | MEDLINE | ID: mdl-35022311

ABSTRACT

Understanding nephron loss is a primary strategy for preventing CKD progression. Death of renal tubular cells may occur by apoptosis during developmental and regenerative processes. However, during AKI, the transition of AKI to CKD, sepsis-associated AKI, and kidney transplantation ferroptosis and necroptosis, two pathways associated with the loss of plasma membrane integrity, kill renal cells. This necrotic type of cell death is associated with an inflammatory response, which is referred to as necroinflammation. Importantly, the necroinflammatory response to cells that die by necroptosis may be fundamentally different from the tissue response to ferroptosis. Although mechanisms of ferroptosis and necroptosis have recently been investigated in detail, the cell death propagation during tubular necrosis, although described morphologically, remains incompletely understood. Here, we argue that a molecular switch downstream of tubular necrosis determines nephron regeneration versus nephron loss. Unraveling the details of this "switch" must include the inflammatory response to tubular necrosis and regenerative signals potentially controlled by inflammatory cells, including the stimulation of myofibroblasts as the origin of fibrosis. Understanding in detail the molecular switch and the inflammatory responses to tubular necrosis can inform the discussion of therapeutic options.


Subject(s)
Acute Kidney Injury , Kidney Cortex Necrosis , Renal Insufficiency, Chronic , Acute Kidney Injury/metabolism , Apoptosis , Female , Humans , Kidney/metabolism , Male , Necrosis/drug therapy , Nephrons/metabolism , Renal Insufficiency, Chronic/metabolism
6.
Ann Clin Lab Sci ; 51(6): 875-882, 2021 Nov.
Article in English | MEDLINE | ID: mdl-34921042

ABSTRACT

OBJECTIVE: Vascular endothelial growth factor (VEGF) antagonists have been used for treating metastatic neoplasms. It has also been known that one of its side effects is to cause proteinuria and renal failure in the setting of thrombotic microangiopathy (TMA). The underlying mechanism is likely due to the inhibition of VEGF production in podocytes, resulting in diffuse fusion of foot processes and impaired glomerular endothelial fenestrations, and leading to massive proteinuria and subsequent glomerular endothelium injury. Intravitreal injection of VEGF antagonists (IIVA) has been also used to treat macular degeneration and diabetic retinal neo-vascular proliferation. The majority of patients tolerate the treatment well. However, IIVA can lead to renal dysfunction including proteinuria and gradual renal failure as a rare side effect. The goal of this study was to report two cases related to the nephrotoxicity of IIVA and review the literature associated with this topic. CASE REPORT: The first diabetic patient had elevated serum creatinine at 3.25 mg/dl and proteinuria/creatinine ratio at 6.1 after 48-month treatment of IIVA. The first renal biopsy revealed thrombotic microangiopathy that was correlated with his increased serum creatinine and nephrotic range of proteinuria. The second diabetic patient had increased serum creatinine up to 1.89 mg/dl but low proteinuria. The second biopsy showed acute tubular necrosis that was correlated with his elevated serum creatinine. CONCLUSION: Intravitreal injection of VEGF antagonist can be associated with thrombotic microangiopathy and acute tubular necrosis, leading to renal dysfunction.


Subject(s)
Acute Kidney Injury , Bevacizumab , Diabetic Retinopathy , Kidney Cortex Necrosis , Retinal Neovascularization , Thrombotic Microangiopathies , Vascular Endothelial Growth Factor A/antagonists & inhibitors , Acute Kidney Injury/blood , Acute Kidney Injury/chemically induced , Acute Kidney Injury/diagnosis , Acute Kidney Injury/therapy , Aged , Angiogenesis Inhibitors/administration & dosage , Angiogenesis Inhibitors/adverse effects , Bevacizumab/administration & dosage , Bevacizumab/adverse effects , Biopsy/methods , Creatinine/blood , Diabetic Retinopathy/complications , Diabetic Retinopathy/diagnosis , Diabetic Retinopathy/drug therapy , Humans , Intravitreal Injections/methods , Kidney Cortex Necrosis/etiology , Kidney Cortex Necrosis/pathology , Kidney Function Tests/methods , Male , Middle Aged , Proteinuria/diagnosis , Proteinuria/etiology , Retinal Neovascularization/diagnostic imaging , Retinal Neovascularization/etiology , Thrombotic Microangiopathies/diagnostic imaging , Thrombotic Microangiopathies/etiology , Treatment Outcome
9.
Medicine (Baltimore) ; 100(21): e25958, 2021 May 28.
Article in English | MEDLINE | ID: mdl-34032705

ABSTRACT

RATIONALE: Anti-angiotensin II type 1 receptor antibodies (AT1R-Abs) have been demonstrated to increase the risk of antibody-mediated rejection. We report a case of AT1R-Ab mediated rejection which caused early critical cortical infarction. PATIENT CONCERNS: A 52-year-old man with end-stage kidney disease underwent preemptive kidney transplantation (KT) from his wife. He had no immunologic risk except ABO incompatibility. Proper desensitization treatment were applied prior to KT. On postoperative day 1, he showed stable clinical course with adequate urine output, but there was no decrease in serum creatinine level and imaging studies showed hypoperfusion in the transplanted kidney. DIAGNOSES: Allograft biopsy revealed total cortical infarction with severe necrotizing vasculitis, but the medullary area was preserved. Serum AT1R-Ab concentration was elevated from 10.9 U/mL before KT to 19.1 U/mL on 7 days after KT. INTERVENTIONS: He was treated with plasmapheresis, intravenous immunoglobulin, rituximab, high-dose methylprednisolone, and bortezomib. OUTCOMES: The treatment showed a partial response, and he was discharged with 7.3 mg/dL creatinine level. At 4 months, his creatinine plateaued at 5.5 mg/dL and AT1R-Ab decreased to 3.6 U/mL. LESSONS: This case highlights the risk of early active antibody-mediated rejection by preformed AT1R-Ab, suggesting its ability to exhibit atypical histopathologic findings, such as total cortical infarction.


Subject(s)
Graft Rejection/immunology , Infarction/immunology , Isoantibodies/blood , Kidney Cortex Necrosis/immunology , Kidney Transplantation/adverse effects , Receptor, Angiotensin, Type 1/immunology , Allografts/blood supply , Allografts/immunology , Allografts/pathology , Female , Graft Rejection/blood , Graft Rejection/diagnosis , Graft Rejection/therapy , Histocompatibility Testing , Humans , Immunologic Factors/administration & dosage , Infarction/blood , Infarction/diagnosis , Infarction/therapy , Isoantibodies/immunology , Kidney Cortex/blood supply , Kidney Cortex/immunology , Kidney Cortex/pathology , Kidney Cortex Necrosis/blood , Kidney Cortex Necrosis/diagnosis , Kidney Cortex Necrosis/therapy , Kidney Failure, Chronic/surgery , Living Donors , Male , Middle Aged , Plasmapheresis , Spouses , Time Factors
10.
Medicina (Kaunas) ; 57(3)2021 Mar 11.
Article in English | MEDLINE | ID: mdl-33799854

ABSTRACT

Renal biopsy is useful to better understand the histological pattern of a lesion (glomerular, tubulointerstitial, and vascular) and the pathogenesis that leads to kidney failure. The potential impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on the kidneys is still undetermined, and a variety of lesions are seen in the kidney tissue of coronavirus disease patients. This review is based on the morphological findings of patients described in case reports and a series of published cases. A search was conducted on MEDLINE and PubMed of case reports and case series of lesions in the presence of non-critical infection by SARS-CoV-2 published until 15/09/2020. We highlight the potential of the virus directly influencing the damage or the innate and adaptive immune response activating cytokine and procoagulant cascades, in addition to the genetic component triggering glomerular diseases, mainly collapsing focal segmental glomerulosclerosis, tubulointerstitial, and even vascular diseases. Kidney lesions caused by SARS-CoV-2 are frequent and have an impact on morbidity and mortality; thus, studies are needed to assess the morphological kidney changes and their mechanisms and may help define their spectrum and immediate or long-term impact.


Subject(s)
Acute Kidney Injury/pathology , COVID-19/pathology , Glomerulonephritis/pathology , Kidney/pathology , Thrombotic Microangiopathies/pathology , Acute Kidney Injury/blood , Acute Kidney Injury/immunology , Adaptive Immunity/immunology , Arteriosclerosis/immunology , Arteriosclerosis/pathology , COVID-19/blood , COVID-19/immunology , Cytokines/immunology , Glomerulonephritis/immunology , Glomerulonephritis, IGA/immunology , Glomerulonephritis, IGA/pathology , Glomerulosclerosis, Focal Segmental/immunology , Glomerulosclerosis, Focal Segmental/pathology , Humans , Immunity, Innate/immunology , Infarction/immunology , Infarction/pathology , Kidney/blood supply , Kidney/immunology , Kidney Cortex Necrosis/immunology , Kidney Cortex Necrosis/pathology , Nephritis, Interstitial/immunology , Nephritis, Interstitial/pathology , Nephrosis, Lipoid/immunology , Nephrosis, Lipoid/pathology , Rhabdomyolysis , SARS-CoV-2 , Thrombophilia/blood , Thrombotic Microangiopathies/immunology
11.
Am J Med Sci ; 362(1): 99-102, 2021 07.
Article in English | MEDLINE | ID: mdl-33872582

ABSTRACT

Tipifarnib is a novel targeted treatment for hematologic malignancies that is being recently studied for the treatment of advanced solid organ tumors with HRAS mutations. There have been scarce reports on kidney adverse events in initial phase I and II trials. We present a case of acute kidney injury in a patient that had started treatment with tipifarnib for advanced squamous cell carcinoma of the lung. Kidney biopsy revealed acute tubular necrosis together with acute interstitial nephritis. Tipifarnib was discontinued and the patient was started with high-dose corticosteroids with an early taper completing a five-week steroid course, with full recovery of kidney function.


Subject(s)
Antineoplastic Agents/adverse effects , Carcinoma, Squamous Cell/drug therapy , Kidney Cortex Necrosis/chemically induced , Lung Neoplasms/drug therapy , Nephritis, Interstitial/chemically induced , Quinolones/adverse effects , Aged , Carcinoma, Squamous Cell/diagnosis , Humans , Kidney Cortex Necrosis/complications , Kidney Cortex Necrosis/diagnosis , Lung Neoplasms/diagnosis , Male , Nephritis, Interstitial/complications , Nephritis, Interstitial/diagnosis
12.
BMC Infect Dis ; 21(1): 231, 2021 Feb 27.
Article in English | MEDLINE | ID: mdl-33639872

ABSTRACT

BACKGROUND: Capnocytophaga canimorsus is a Gram-negative capnophilic rod and part of dogs/cats' normal oral flora. It can be transmitted by bites, scratches, or even by contact of saliva with injured skin. Asplenic patients and patients with alcohol abuse are at particular risk for fulminant C. canimorsus sepsis. However, also immunocompetent patients can have a severe or even fatal infection. This is the first case of a severe C. canimorsus infection in an immunocompromised host complicated by acute renal cortical necrosis with a "reverse rim sign" in contrast-enhanced computed tomography on hospital admission. CASE PRESENTATION: We report the case of a 44-year functionally asplenic patient after an allogeneic stem cell transplantation, who presented with septic shock after a minor dog bite injury 4 days prior. Because of abdominal complaints, epigastric pain with local peritonism, and radiological gallbladder wall thickening, an abdominal focus was suspected after the initial work-up. The patient underwent emergent open cholecystectomy, but the clinical suspicion of abdominal infection was not confirmed. Septic shock was further complicated by cardiomyopathy and disseminated intravascular coagulation. As a causative pathogen, C. canimorsus could be isolated. The clinical course was complicated by permanent hemodialysis and extensive acral necrosis requiring amputation of several fingers and both thighs. CONCLUSION: We present a severe case of a C. canimorsus infection in a functionally asplenic patient after a minor dog bite. The clinical course was complicated by septic shock, disseminated intravascular coagulation, and the need for multiple amputations. In addition, the rare form of acute renal failure - bilateral acute renal cortical necrosis - was visible as "reverse rim sign" on computed tomography scan. This case is an example of the potential disastrous consequences when omitting pre-emptive antibiotic therapy in wounds inflicted by cats and dogs, particularly in asplenic patients.


Subject(s)
Bites and Stings/complications , Bites and Stings/microbiology , Capnocytophaga , Gram-Negative Bacterial Infections/complications , Kidney Cortex Necrosis/microbiology , Adult , Amputation, Surgical , Animals , Anti-Bacterial Agents/therapeutic use , Bites and Stings/therapy , Capnocytophaga/isolation & purification , Capnocytophaga/pathogenicity , Disseminated Intravascular Coagulation/microbiology , Disseminated Intravascular Coagulation/pathology , Disseminated Intravascular Coagulation/therapy , Dogs , Female , Gram-Negative Bacterial Infections/pathology , Gram-Negative Bacterial Infections/therapy , Humans , Immunocompromised Host , Intraabdominal Infections/etiology , Intraabdominal Infections/microbiology , Intraabdominal Infections/therapy , Kidney Cortex Necrosis/etiology , Kidney Cortex Necrosis/therapy , Shock, Septic/microbiology , Shock, Septic/therapy , Switzerland
13.
Sci Rep ; 11(1): 2060, 2021 01 21.
Article in English | MEDLINE | ID: mdl-33479443

ABSTRACT

Renal cortical necrosis (RCN) is a rare cause of acute kidney failure and is usually diagnosed on the basis of characteristic enhancement patterns on cross-sectional imaging. Contrast-enhanced ultrasound (CEUS) offers benefits in patients with kidney failure in the clinical setting including the use of a nonnephrotoxic intravascular contrast agent and the fact that it can be performed at the bedside in critical cases. Therefore, the aim of this study is to investigate whether CEUS can reliably identify typical imaging features of RCN. We retrospectively analyzed 12 patients with RCN examined in our department and confirmation of the diagnosis by either histopathology, other contrast-enhanced cross-sectional imaging tests, and/or CEUS follow-up. Assessed parameters in conventional US were reduced echogenicity, loss of corticomedullary differentiation, length and width of kidney, hypoechoic rim, resistance index and in CEUS delayed wash-in of contrast agent (> 20 s), reverse rim sign, maximum nonenhancing rim and additional renal infarction. Furthermore, imaging features in RCN were compared with the findings in renal vein thrombosis (RVT), among them echogenicity, corticomedullar differentiation, hypoechoic rim, RI value, delayed cortical enhancement, total loss of cortical perfusion and enhancement of renal medulla. All 12 patients showed the reverse rim sign, while a hypoechogenic subcapsular rim was only visible in four patients on B-mode ultrasound. A resistance index (RI) was available in 10 cases and was always less than 1. RI was a strong differentiator in separating RVT from RCN (RI > 1 or not measurable due to hypoperfusion as differentiator, p = 0.001). CEUS showed total loss of medullary enhancement in all cases of RVT. With its higher temporal resolution, CEUS allows dynamic assessment of renal macro- and microcirculation and identification of the typical imaging findings of RCN with use of a nonnephrotoxic contrast agent.


Subject(s)
Acute Kidney Injury/diagnosis , Kidney Cortex Necrosis/diagnosis , Rare Diseases/diagnosis , Ultrasonography , Acute Kidney Injury/diagnostic imaging , Acute Kidney Injury/etiology , Acute Kidney Injury/pathology , Adult , Aged , Contrast Media/administration & dosage , Female , Humans , Kidney Cortex Necrosis/complications , Kidney Cortex Necrosis/diagnostic imaging , Kidney Cortex Necrosis/pathology , Male , Middle Aged , Rare Diseases/complications , Rare Diseases/diagnostic imaging , Rare Diseases/pathology
14.
Nephrology (Carlton) ; 26(1): 30-37, 2021 Jan.
Article in English | MEDLINE | ID: mdl-32602136

ABSTRACT

AIM: Due to the accumulating evidence of complement activation in anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis (AAV), we decided to investigate the possibility of systemic complement activation in patients with Necrotizing Glomerulonephritis secondary to AAV. METHODS: Clinical, laboratory and histological findings, and serum levels of complement components, C3a, C5a and Bb fragment of Factor B and C4d, were estimated in patients with AAV and glomerulonephritis, at time of diagnosis, before any treatment had been applied. All patients were treated with the same immunosuppressive protocol and followed up for total 24 months. Twenty age and sex matched healthy individuals served as controls. RESULTS: Serum levels of all complement components were significantly increased in patients, compared to controls; C5a: 19.9(0.02-48) vs 9.06(2.1-16.3)pg/mL, P = .002, Bb: 7.3(0.02-31.4) vs 0.2(0.02-1.6)pg/mL, P < .0001, C3a: 4.7(0.4-7.2) vs 2.4(1.09-5)pg/mL, P = .05 and C4d: 11.6(0.07-70) vs 0.7(0.07-8.2)pg/mL, P = .001, respectively. There was strong correlation between serum Bb levels and eGFR and FFS2009 score at time of diagnosis (r = -.41, P = .002 and r = .41, P = .003 respectively). Also, serum Bb levels were increased in patients with severe interstitial infiltration (P = .04) and focal necrosis (P = .01) on renal biopsy. Serum Bb levels could also predict renal function outcome during the acute phase of disease, but not at the end of follow up. CONCLUSION: We provided strong evidence of systemic activation of complement alternative pathway in the development and progression of AAV and glomerulonephritis. Serum Bb seem to play a critical role in the induction, also predicting disease activity and outcome, yet activation of classical pathway cannot be excluded.


Subject(s)
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis , Complement Activation/immunology , Complement Pathway, Alternative/immunology , Complement System Proteins , Glomerulonephritis , Kidney Cortex Necrosis/pathology , Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/complications , Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/immunology , Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/therapy , Biopsy/methods , Complement System Proteins/analysis , Complement System Proteins/classification , Correlation of Data , Female , Glomerulonephritis/etiology , Glomerulonephritis/immunology , Glomerulonephritis/pathology , Glomerulonephritis/therapy , Greece/epidemiology , Humans , Immunosuppressive Agents/therapeutic use , Kidney Function Tests/methods , Male , Middle Aged , Outcome Assessment, Health Care
15.
Adv Chronic Kidney Dis ; 27(5): 397-403, 2020 09.
Article in English | MEDLINE | ID: mdl-33308505

ABSTRACT

Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a rapidly spreading pandemic. Owing to changes in the immune system and respiratory physiology, pregnant women are vulnerable to severe viral pneumonia. We review the clinical course, pregnancy outcomes, and management of women with COVID-19 in pregnancy with a focus on those with kidney involvement. Current evidence does not show an increased risk of acquiring SARS-CoV-2 during pregnancy and the maternal course appears to be similar to nonpregnant patients. However, severe maternal disease can lead to complex management challenges and has shown to be associated with higher incidence of preterm and caesarean births. The risk of congenital infection with SARS-CoV-2 is not known. All neonates must be considered as high-risk contacts and should be screened at birth and isolated. Pregnant women should follow all measures to prevent SARS-CoV-2 exposure and this fear should not compromise antenatal care. Use of telemedicine, videoconferencing, and noninvasive fetal and maternal home monitoring devices should be encouraged. High-risk pregnant patients with comorbidities and COVID-19 require hospitalization and close monitoring. Pregnant women with COVID-19 and kidney disease are a high-risk group and should be managed by a multidisciplinary team approach including a nephrologist and neonatologist.


Subject(s)
Acute Kidney Injury/therapy , COVID-19/therapy , Kidney Transplantation , Pregnancy Complications, Infectious/therapy , Pregnancy Complications/therapy , Renal Insufficiency, Chronic/therapy , Acute Kidney Injury/etiology , COVID-19/complications , COVID-19/prevention & control , COVID-19/transmission , Cesarean Section/statistics & numerical data , Diagnosis, Differential , Disease Management , Female , Humans , Infectious Disease Transmission, Vertical , Kidney Cortex Necrosis/complications , Kidney Cortex Necrosis/diagnosis , Patient Care Team , Pre-Eclampsia/diagnosis , Pregnancy , Premature Birth/epidemiology , Prenatal Care/methods , Pyelonephritis/complications , Pyelonephritis/diagnosis , Renal Insufficiency, Chronic/complications , SARS-CoV-2 , Telemedicine/methods , Thrombotic Microangiopathies/complications , Thrombotic Microangiopathies/diagnosis
16.
Intern Med J ; 50(12): 1551-1558, 2020 12.
Article in English | MEDLINE | ID: mdl-33354883

ABSTRACT

Nephrotic range proteinuria has been reported during the course of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease (COVID-19). However, the pathological mechanisms underlying this manifestation are unknown. In this article, we present two cases of collapsing glomerulopathy (CG) associated with acute tubular necrosis during the course of COVID-19, and review the literature for similar reports. In our two cases, as in the 14 cases reported so far, the patients were of African ancestry. The 14 patients assessed had an APOL1 high-risk genotype. At the end of the reported period, two patients had died and five patients were still requiring dialysis. The 16 cases detailed in the present report strongly argue in favour of a causal link between SARS-CoV-2 infection and the occurrence of CG in patients homozygous for APOL1 high-risk genotype for which the term COVID-associated nephropathy (COVIDAN) can be put forward.


Subject(s)
Acute Kidney Injury/diagnosis , Acute Kidney Injury/etiology , COVID-19/complications , COVID-19/diagnosis , Kidney Cortex Necrosis/diagnosis , Kidney Cortex Necrosis/etiology , Adult , Female , Humans , Middle Aged
17.
Histopathology ; 77(6): 926-935, 2020 Dec.
Article in English | MEDLINE | ID: mdl-32516862

ABSTRACT

AIMS: An important role of native kidney biopsy evaluation is to predict renal prognosis. We aimed to develop a simplified chronicity score based solely on pathological features that are easily recognisable and can be found in all glomerular nephropathies (GN). In this retrospective study, observational cohort study we included 625 patients with GN diagnosis after native kidney biopsy in a tertiary unit between 1 January 2010 and 31 December 2015. METHODS AND RESULTS: Presence of global glomerulosclerosis (GG), tubular atrophy (TA), interstitial fibrosis (IF) and fibrocellular/fibrous crescents (FC) in any grade was scored with one point; a final score was between 0 and 4 (i.e. 'absent' 0 score, 'moderate' 1-2 score, 'severe' 3-4 score). The primary endpoint was renal replacement therapy (RRT) initiation. Mean baseline estimated glomerular filtration rate (eGFR) was 55.9 ± 29.6 ml/min; during the follow-up (median = 27 months), 78 patients started RRT. The total mean renal survival time was 60.1 (58.0-62.1) months. GG (41%) was the most frequent lesion, followed by IF (25%), TA (18%) and FC (17%). Patients with absent (65.7; 63.6-67.8 months) chronicity had better renal survival than those with moderate (59.1; 56.1-62.2 months) or severe (42.7; 35.6-49.7 months) chronicity. The score was associated with renal survival [hazard ratio (HR) = 1.33; 1.08-1.64)] independently of the classical prognostic factors. Patients with moderate and severe chronicity had a two- and threefold increase in risk of RRT initiation. CONCLUSION: Our score was correlated with renal survival independently of the traditional risk factors, and could improve outcome prediction in patients with GN by reducing the interobserver variability.


Subject(s)
Kidney Glomerulus/pathology , Kidney/pathology , Prognosis , Adult , Biopsy , Cohort Studies , Female , Fibrosis , Glomerular Filtration Rate , Glomerulosclerosis, Focal Segmental/pathology , Humans , Kidney Cortex Necrosis/pathology , Kidney Diseases/diagnosis , Kidney Diseases/pathology , Kidney Failure, Chronic/pathology , Male , Middle Aged , Proportional Hazards Models , Renal Replacement Therapy , Retrospective Studies , Risk Factors
18.
Int J Mol Sci ; 21(10)2020 May 22.
Article in English | MEDLINE | ID: mdl-32455976

ABSTRACT

Cyclophilin A (CypA) is a highly abundant protein in the cytoplasm of most mammalian cells. Beyond its homeostatic role in protein folding, CypA is a Damage-Associated Molecular Pattern which can promote inflammation during tissue injury. However, the role of CypA in kidney disease is largely unknown. This study investigates the contribution of CypA in two different types of kidney injury: acute tubular necrosis and progressive interstitial fibrosis. CypA (Ppia) gene deficient and wild type (WT) littermate controls underwent bilateral renal ischaemia/reperfusion injury (IRI) and were killed 24h later or underwent left unilateral ureteric obstruction (UUO) and were killed 7 days later. In the IRI model, CypA-/- mice showed substantial protection against the loss of renal function and from tubular cell damage and death. This was attributed to a significant reduction in neutrophil and macrophage infiltration since CypA-/- tubular cells were not protected from oxidant-induced cell death in vitro. In the UUO model, CypA-/- mice were not protected from leukocyte infiltration or renal interstitial fibrosis. In conclusion, CypA promotes inflammation and acute kidney injury in renal IRI, but does not contribute to inflammation or interstitial fibrosis in a model of progressive kidney fibrosis.


Subject(s)
Acute Kidney Injury/metabolism , Cyclophilin A/metabolism , Kidney Cortex Necrosis/metabolism , Kidney/pathology , Reperfusion Injury/metabolism , Acute Kidney Injury/genetics , Animals , Cell Death/drug effects , Cell Death/genetics , Cells, Cultured , Cyclophilin A/genetics , Disease Models, Animal , Epithelial Cells/metabolism , Fibrosis/genetics , Fibrosis/metabolism , Inflammation/genetics , Inflammation/metabolism , Inflammation/pathology , Kidney/metabolism , Kidney Cortex Necrosis/genetics , Kidney Tubules/drug effects , Kidney Tubules/metabolism , Kidney Tubules/pathology , Macrophages/metabolism , Male , Mice , Mice, Knockout , Neutrophils/metabolism , Oxidative Stress/drug effects , Oxidative Stress/genetics , Reperfusion Injury/genetics , Ureteral Obstruction/metabolism
19.
Int J Mol Sci ; 22(1)2020 Dec 29.
Article in English | MEDLINE | ID: mdl-33383945

ABSTRACT

Cyclophilins have important homeostatic roles, but following tissue injury, cyclophilin A (CypA) can promote leukocyte recruitment and inflammation, while CypD can facilitate mitochondrial-dependent cell death. This study investigated the therapeutic potential of a selective cyclophilin inhibitor (GS-642362), which does not block calcineurin function, in mouse models of tubular cell necrosis and renal fibrosis. Mice underwent bilateral renal ischemia/reperfusion injury (IRI) and were killed 24 h later: treatment with 10 or 30 mg/kg/BID GS-642362 (or vehicle) began 1 h before surgery. In the second model, mice underwent unilateral ureteric obstruction (UUO) surgery and were killed 7 days later; treatment with 10 or 30 mg/kg/BID GS-642362 (or vehicle) began 1 h before surgery. GS-642362 treatment gave a profound and dose-dependent protection from acute renal failure in the IRI model. This protection was associated with reduced tubular cell death, including a dramatic reduction in neutrophil infiltration. In the UUO model, GS-642362 treatment significantly reduced tubular cell death, macrophage infiltration, and renal fibrosis. This protective effect was independent of the upregulation of IL-2 and activation of the stress-activated protein kinases (p38 and JNK). In conclusion, GS-642362 was effective in suppressing both acute kidney injury and renal fibrosis. These findings support further investigation of cyclophilin blockade in other types of acute and chronic kidney disease.


Subject(s)
Acute Kidney Injury/etiology , Acute Kidney Injury/prevention & control , Cyclophilins/pharmacology , Kidney Cortex Necrosis/etiology , Kidney Cortex Necrosis/prevention & control , Protective Agents/pharmacology , Acute Kidney Injury/pathology , Animals , Cell Death , Disease Models, Animal , Fibrosis , Kidney Cortex Necrosis/pathology , Kidney Tubules/metabolism , Macrophages/metabolism , Macrophages/pathology , Mice , Neutrophil Infiltration , Neutrophils/metabolism , Neutrophils/pathology , Oxygen/metabolism , Reperfusion Injury/etiology , Reperfusion Injury/metabolism , Reperfusion Injury/pathology
20.
Saudi J Kidney Dis Transpl ; 31(6): 1395-1398, 2020.
Article in English | MEDLINE | ID: mdl-33565452

ABSTRACT

Bilateral renal cortical necrosis (RCN) as a cause of acute kidney injury is very rare in the pediatric population. Progression to end-stage renal disease is seen virtually in every patient with RCN. There are many causes for the occurrence of cortical necrosis in children, with severe pancreatitis being a rarity. In this report, we describe a child with severe acute pancreatitis complicated by bilateral RCN.


Subject(s)
Kidney Cortex Necrosis/etiology , Pancreatitis/complications , Acute Kidney Injury/etiology , Anuria/etiology , Child , Female , Humans , Kidney Cortex Necrosis/diagnostic imaging , Pancreatitis/diagnosis
SELECTION OF CITATIONS
SEARCH DETAIL
...